Triazolopyridine ethers as potent, orally active mGlu2 positive allosteric modulators for treating schizophrenia. Issue 2 (15th January 2017)
- Record Type:
- Journal Article
- Title:
- Triazolopyridine ethers as potent, orally active mGlu2 positive allosteric modulators for treating schizophrenia. Issue 2 (15th January 2017)
- Main Title:
- Triazolopyridine ethers as potent, orally active mGlu2 positive allosteric modulators for treating schizophrenia
- Authors:
- Higgins, Mendi A.
Marcin, Lawrence R.
Christopher Zusi, F.
Gentles, Robert
Ding, Min
Pearce, Bradley C.
Easton, Amy
Kostich, Walter A.
Seager, Matthew A.
Bourin, Clotilde
Bristow, Linda J.
Johnson, Kim A.
Miller, Regina
Hogan, John
Whiterock, Valerie
Gulianello, Michael
Ferrante, Meredith
Huang, Yanling
Hendricson, Adam
Alt, Andrew
Macor, John E.
Bronson, Joanne J. - Abstract:
- Graphical abstract: Abstract: Triazolopyridine ethers with mGlu2 positive allosteric modulator (PAM) activity are disclosed. The synthesis, in vitro activity, and metabolic stability data for a series of analogs is provided. The effort resulted in the discovery of a potent, selective, and brain penetrant lead molecule BMT-133218 ((+)-7m ). After oral administration at 10 mg/kg, BMT-133218 demonstrated full reversal of PCP-stimulated locomotor activity and prevented MK-801-induced working memory deficits in separate mouse models. Also, reversal of impairments in executive function were observed in rat set-shifting studies at 3 and 10 mg/kg ( p.o .). Extensive plasma protein binding as the result of high lipophilicity likely limited activity at lower doses. Optimized triazolopyridine ethers offer utility as mGlu2 PAMs for the treatment of schizophrenia and merit further preclinical investigation.
- Is Part Of:
- Bioorganic & medicinal chemistry. Volume 25:Issue 2(2017)
- Journal:
- Bioorganic & medicinal chemistry
- Issue:
- Volume 25:Issue 2(2017)
- Issue Display:
- Volume 25, Issue 2 (2017)
- Year:
- 2017
- Volume:
- 25
- Issue:
- 2
- Issue Sort Value:
- 2017-0025-0002-0000
- Page Start:
- 496
- Page End:
- 513
- Publication Date:
- 2017-01-15
- Subjects:
- Schizophrenia -- mGlu2 -- Metabotropic glutamate receptors -- Triazolopyridine
Bioorganic chemistry -- Periodicals
Pharmaceutical chemistry -- Periodicals
Biochemistry -- Periodicals
Chemistry, Clinical -- Periodicals
Chemistry, Organic -- Periodicals
Chimie bio-organique -- Périodiques
Chimie pharmaceutique -- Périodiques
615.19 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09680896 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.bmc.2016.11.018 ↗
- Languages:
- English
- ISSNs:
- 0968-0896
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2089.325000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 1091.xml